These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Regulatory network of BLIMP1, IRF4, and XBP1 triad in plasmacytic differentiation and multiple myeloma pathogenesis. Tang TF; Chan YT; Cheong HC; Cheok YY; Anuar NA; Looi CY; Gan GG; Wong WF Cell Immunol; 2022 Oct; 380():104594. PubMed ID: 36081178 [TBL] [Abstract][Full Text] [Related]
7. IRF4 promotes cell proliferation by JNK pathway in multiple myeloma. Zhang S; Xu J; Wu S; Wang R; Qu X; Yu W; Li J; Chen L Med Oncol; 2013; 30(2):594. PubMed ID: 23666852 [TBL] [Abstract][Full Text] [Related]
8. Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development. Yamamoto M; Kato T; Hotta C; Nishiyama A; Kurotaki D; Yoshinari M; Takami M; Ichino M; Nakazawa M; Matsuyama T; Kamijo R; Kitagawa S; Ozato K; Tamura T PLoS One; 2011; 6(10):e25812. PubMed ID: 22003407 [TBL] [Abstract][Full Text] [Related]
9. The molecular choreography of IRF4 and IRF8 with immune system partners. Singh H; Glasmacher E; Chang AB; Vander Lugt B Cold Spring Harb Symp Quant Biol; 2013; 78():101-4. PubMed ID: 24752218 [TBL] [Abstract][Full Text] [Related]
10. IRF4 Activity Is Required in Established Plasma Cells to Regulate Gene Transcription and Mitochondrial Homeostasis. Low MSY; Brodie EJ; Fedele PL; Liao Y; Grigoriadis G; Strasser A; Kallies A; Willis SN; Tellier J; Shi W; Gabriel S; O'Donnell K; Pitt C; Nutt SL; Tarlinton D Cell Rep; 2019 Nov; 29(9):2634-2645.e5. PubMed ID: 31775034 [TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function. Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624 [TBL] [Abstract][Full Text] [Related]
12. PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4. Ueno N; Nishimura N; Ueno S; Endo S; Tatetsu H; Hirata S; Hata H; Matsuoka M; Mitsuya H; Okuno Y Oncogene; 2017 Aug; 36(31):4481-4497. PubMed ID: 28368411 [TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4. Carreras E; Turner S; Frank MB; Knowlton N; Osban J; Centola M; Park CG; Simmons A; Alberola-Ila J; Kovats S Blood; 2010 Jan; 115(2):238-46. PubMed ID: 19880499 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages. Lehtonen A; Veckman V; Nikula T; Lahesmaa R; Kinnunen L; Matikainen S; Julkunen I J Immunol; 2005 Nov; 175(10):6570-9. PubMed ID: 16272311 [TBL] [Abstract][Full Text] [Related]
15. The diverse roles of IRF4 in late germinal center B-cell differentiation. De Silva NS; Simonetti G; Heise N; Klein U Immunol Rev; 2012 May; 247(1):73-92. PubMed ID: 22500833 [TBL] [Abstract][Full Text] [Related]
16. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Klein U; Casola S; Cattoretti G; Shen Q; Lia M; Mo T; Ludwig T; Rajewsky K; Dalla-Favera R Nat Immunol; 2006 Jul; 7(7):773-82. PubMed ID: 16767092 [TBL] [Abstract][Full Text] [Related]
17. IRF4 controls the positioning of mature B cells in the lymphoid microenvironments by regulating NOTCH2 expression and activity. Simonetti G; Carette A; Silva K; Wang H; De Silva NS; Heise N; Siebel CW; Shlomchik MJ; Klein U J Exp Med; 2013 Dec; 210(13):2887-902. PubMed ID: 24323359 [TBL] [Abstract][Full Text] [Related]
18. Lineage- and Stage-Specific Oncogenicity of IRF4. Amanda S; Tan TK; Iida S; Sanda T Exp Hematol; 2022 Oct; 114():9-17. PubMed ID: 35908629 [TBL] [Abstract][Full Text] [Related]
19. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Tsuboi K; Iida S; Inagaki H; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Kikuchi M; Komatsu H; Banno S; Wakita A; Nakamura S; Eimoto T; Ueda R Leukemia; 2000 Mar; 14(3):449-56. PubMed ID: 10720141 [TBL] [Abstract][Full Text] [Related]
20. Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response. Lopez-Girona A; Heintel D; Zhang LH; Mendy D; Gaidarova S; Brady H; Bartlett JB; Schafer PH; Schreder M; Bolomsky A; Hilgarth B; Zojer N; Gisslinger H; Ludwig H; Daniel T; Jäger U; Chopra R Br J Haematol; 2011 Aug; 154(3):325-36. PubMed ID: 21707574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]